Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published in final edited form as: J Immunol. 2021 Jul 19;207(3):950–965. doi: 10.4049/jimmunol.2100162

Figure 6. Expression of leukocyte-specific integrins by in vitro derived human NK cells.

Figure 6.

NK cells were differentiated in vitro with co-culture on EL08.1D2 or OP9 stromal cells and their phenotype was analyzed at week 4 by flow cytometry. Percent of NK cells expressing CD11a, CD11b, CD11c, CD103, and CD18 (left panel) and their respective density (right panel), by MFI, on in vitro derived NK cells from EL08.1D2 (A, C, E, G, I) and OP9 (B, D, F, H, J) conditions. n= 4–5 biological repeats per stromal cell condition. Statistical significance was tested by ordinary one-way ANOVA with multiple comparisons. P-values from multiple comparisons are reported in Supp. Fig. 2C, D.